Awareness campaign

Women’s Invisible Enemy: Iron Deficiency and IBSA’s Partnership with Almafarmacie for Prevention

15

Do you ever wake up already feeling tired, with heavy muscles, or struggling to focus, and just brush it off with a simple “I’m just a little stressed”?

Very often, what we consider to be normal daily fatigue hides a specific and definitely underestimated biological problem: iron deficiency.

The numbers speak for themselves: it is estimated that this deficiency affects between 25% and 50% of women of childbearing age, practically one in two, and often presents with common symptoms that are, however, at risk of being underestimated or attributed to the hectic pace of daily life.

To raise awareness of this issue and turn prevention into concrete action, IBSA Italy and Almafarmacie joined forces across the country in celebration of Mother’s Day. The initiative allowed over 1,000 women to take a free ferritin test in more than 70 Italian pharmacies, offering not only a quick screening but also a valuable opportunity to learn how to listen to their bodies’ signals and stop putting off their own well-being.

A simple gesture that goes beyond prevention to take care of yourself

17

The initiative was conceived with the aim of reminding people how important it is to listen to their bodies and take care of their health, even through small preventive measures.

In addition to offering the opportunity to take the test, the project also served as an occasion to dispel some widespread myths about iron deficiency and promote greater awareness of the signs that may indicate this condition.

Our collaboration with healthcare professionals and the local community underscores the importance of developing awareness initiatives that can translate public awareness into tangible, accessible support for people.

Raising Awareness and Innovation for the Benefit of Patients

Raising awareness of issues related to iron deficiency is one aspect of IBSA Italy’s commitment to women’s health. Alongside its awareness-raising efforts, the company continues to invest in the research and development of innovative therapeutic solutions, with a particular focus on treatment adherence and patients’ quality of life.

16